Bristol-Myers Squibb Company (NYSE:BMY) has scheduled a conference call for 5th November 2020 at 8:30 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.bms.com
Earnings Expectation
Bristol-Myers Squibb Company is set to announce third quarter earning results on Thursday 5th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, BMY to report 3Q20 income of $ 1.49 per share. For the full year, analysts anticipate top line of $ 41957.40 million, while looking forward to income of $ 6.27 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 40,500.00 million ~ $ 42,000.00 million, where as bottomline are predicted in a range of $ 6.10 ~ $ 6.25 per share
Click Here For More Historical Outlooks Of Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The companys products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.
